UBS Group’s Ekso Bionics EKSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19 Sell
6
-90
-94% -$285 ﹤0.01% 8796
2025
Q1
$580 Buy
96
+86
+860% +$520 ﹤0.01% 8408
2024
Q4
$94 Hold
10
﹤0.01% 8413
2024
Q3
$172 Sell
10
-104
-91% -$1.79K ﹤0.01% 7875
2024
Q2
$1.81K Sell
114
-371
-76% -$5.89K ﹤0.01% 7321
2024
Q1
$9.9K Buy
485
+425
+708% +$8.67K ﹤0.01% 6088
2023
Q4
$2.27K Buy
60
+50
+500% +$1.89K ﹤0.01% 6920
2023
Q3
$108 Sell
10
-1
-9% -$11 ﹤0.01% 7712
2023
Q2
$229 Sell
11
-162
-94% -$3.37K ﹤0.01% 7280
2023
Q1
$4.29K Sell
173
-365
-68% -$9.05K ﹤0.01% 7107
2022
Q4
$9.6K Buy
538
+530
+6,625% +$9.46K ﹤0.01% 7437
2022
Q3
$0 Sell
8
-394
-98% ﹤0.01% 9318
2022
Q2
$10K Buy
402
+393
+4,367% +$9.78K ﹤0.01% 6914
2022
Q1
$0 Sell
9
-497
-98% ﹤0.01% 9266
2021
Q4
$20K Buy
506
+488
+2,711% +$19.3K ﹤0.01% 6717
2021
Q3
$1K Sell
18
-141
-89% -$7.83K ﹤0.01% 8015
2021
Q2
$13K Buy
159
+60
+61% +$4.91K ﹤0.01% 6678
2021
Q1
$9K Sell
99
-973
-91% -$88.5K ﹤0.01% 6970
2020
Q4
$99K Sell
1,072
-168
-14% -$15.5K ﹤0.01% 4709
2020
Q3
$88K Buy
1,240
+1,069
+625% +$75.9K ﹤0.01% 4431
2020
Q2
$22K Buy
171
+154
+906% +$19.8K ﹤0.01% 5643
2020
Q1
$1K Sell
17
-41
-71% -$2.41K ﹤0.01% 6824
2019
Q4
$5K Buy
58
+49
+544% +$4.22K ﹤0.01% 6493
2019
Q3
$1K Sell
9
-60
-87% -$6.67K ﹤0.01% 6854
2019
Q2
$20K Buy
69
+29
+73% +$8.41K ﹤0.01% 5733
2019
Q1
$22K Buy
40
+10
+33% +$5.5K ﹤0.01% 5390
2018
Q4
$9K Buy
30
+23
+329% +$6.9K ﹤0.01% 6349
2018
Q3
$4K Sell
7
-84
-92% -$48K ﹤0.01% 6634
2018
Q2
$37K Buy
91
+36
+65% +$14.6K ﹤0.01% 5323
2018
Q1
$19K Buy
55
+1
+2% +$345 ﹤0.01% 5571
2017
Q4
$26K Buy
54
+47
+671% +$22.6K ﹤0.01% 5384
2017
Q3
$2K Sell
7
-61
-90% -$17.4K ﹤0.01% 6538
2017
Q2
$35K Buy
68
+35
+106% +$18K ﹤0.01% 4977
2017
Q1
$30K Buy
33
+10
+43% +$9.09K ﹤0.01% 4949
2016
Q4
$21K Buy
23
+5
+28% +$4.57K ﹤0.01% 5542
2016
Q3
$19K Buy
+18
New +$19K ﹤0.01% 5428